Pembrolizumab efficacy in a tumor mutation burden-high glioblastoma patient: A case study and implications for precision oncology.
Nishiyama A, Sato S, Sakaguchi H, Kotani H, Yamashita K, Ohtsubo K, Sekiya T, Watanabe A, Tajima A, Shimaguchi C, Mizuguchi K, Ikeda H, Kinoshita M, Nakada M, Takeuchi S.
Nishiyama A, et al. Among authors: sekiya t.
Cancer Sci. 2024 Oct 25. doi: 10.1111/cas.16370. Online ahead of print.
Cancer Sci. 2024.
PMID: 39453824
Free article.